SAN FRANCISCO, April 23, 2018 /PRNewswire/ -- OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, announced today the appointment of Gary M. Phillips, M.D. as President and Chief Executive Officer. Dr. Phillips has over two decades of...
|
Press Release
|